Lipid metabolism-related gene signature predicts prognosis and unveils novel anti-tumor drugs in specific type of diffuse large B cell lymphoma
Abstract Background Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma which possess highly aggressive and heterogeneous. Despite advances in understanding heterogeneity and development of novel targeted agents, the prognosis of DLBCL patients remains unsatisfied. Lipids are c...
Saved in:
Main Authors: | Cancan Wang (Author), Ran Zhang (Author), Huan Zhang (Author), Haixia Gao (Author), Yubing Zhu (Author), Lichao Jiao (Author), Zhiqiang Yi (Author), Meiyu Zhou (Author), Xinxia Li (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: a single center experience
by: Wan-Ming Hu, et al.
Published: (2019) -
Composite lymphoma with coexistence of diffuse large B-cell lymphoma and anaplastic large cell lymphoma: Diagnostic pitfalls
by: Meyyappa Devan Rajagopal, et al.
Published: (2017) -
Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression
by: Abd AlRahman Mohammad Foda MD, et al.
Published: (2023) -
Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression
by: Abd AlRahman Mohammad Foda MD, et al.
Published: (2023) -
High <it>MET</it> gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma
by: Huang Wan-Ting, et al.
Published: (2013)